Akero Therapeutics (AKRO) Insider Trading & Ownership $53.77 +0.05 (+0.09%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$53.76 -0.02 (-0.03%) As of 10/24/2025 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Akero Therapeutics (NASDAQ:AKRO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.07%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$15.86MNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$42.10M Get AKRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Akero Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AKRO Insider Buying and Selling by Quarter Akero Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/10/2025Andrew ChengCEOSell30,000$53.98$1,619,400.00 10/7/2025Timothy RolphInsiderSell12,500$46.08$576,000.00 10/1/2025Jonathan YoungCOOSell12,500$47.76$597,000.00 9/11/2025Andrew ChengCEOSell1,796$43.02$77,263.92 9/11/2025Catriona YaleInsiderSell659$43.02$28,350.18 9/11/2025Jonathan YoungCOOSell586$43.02$25,209.72 9/11/2025Timothy RolphInsiderSell553$43.02$23,790.06 9/11/2025William Richard WhiteCFOSell659$43.02$28,350.18 9/10/2025Andrew ChengCEOSell30,000$43.25$1,297,500.00 9/8/2025Timothy RolphInsiderSell12,500$44.17$552,125.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/2/2025Jonathan YoungCOOSell12,500$46.08$576,000.00 8/12/2025Jonathan YoungCOOSell12,500$47.79$597,375.00 8/11/2025Andrew ChengCEOSell30,000$48.59$1,457,700.00 8/5/2025Timothy RolphInsiderSell12,500$49.30$616,250.00 7/16/2025Catriona YaleInsiderSell10,000$52.95$529,500.00 7/10/2025Andrew ChengCEOSell30,000$51.16$1,534,800.00 7/7/2025Timothy RolphInsiderSell12,500$51.09$638,625.00 7/1/2025Patrick LamyVPSell2,000$52.88$105,760.00 6/20/2025Patrick LamyVPSell875$54.59$47,766.25 6/18/2025Andrew ChengCEOSell6,620$54.84$363,040.80 6/18/2025Catriona YaleInsiderSell1,633$54.84$89,553.72 6/18/2025Jonathan YoungCOOSell1,453$54.84$79,682.52 6/18/2025Scott A GangloffCTOSell848$54.84$46,504.32 6/18/2025Timothy RolphInsiderSell1,129$54.84$61,914.36 6/18/2025William Richard WhiteCFOSell1,634$54.84$89,608.56 6/16/2025Catriona YaleInsiderSell10,000$54.23$542,300.00 6/16/2025Patrick LamyVPSell2,000$54.14$108,280.00 6/10/2025Andrew ChengCEOSell37,837$54.05$2,045,089.85 6/10/2025Catriona YaleInsiderSell2,803$54.00$151,362.00 6/10/2025Jonathan YoungCOOSell2,493$53.99$134,597.07 6/10/2025Patrick LamyVPSell919$54.00$49,626.00 6/10/2025Timothy RolphInsiderSell2,358$54.00$127,332.00 6/10/2025William Richard WhiteCFOSell2,804$53.99$151,387.96 6/6/2025Timothy RolphInsiderSell25,000$55.04$1,376,000.00 6/5/2025Timothy RolphInsiderSell12,500$53.49$668,625.00 6/2/2025Patrick LamyVPSell4,000$50.31$201,240.00 5/22/2025Patrick LamyVPSell4,000$50.00$200,000.00 5/15/2025Catriona YaleInsiderSell10,000$39.30$393,000.00 5/12/2025Andrew ChengCEOSell30,000$41.48$1,244,400.00 5/7/2025Patrick LamyVPSell8,000$42.49$339,920.00 5/6/2025Timothy RolphInsiderSell12,500$43.43$542,875.00 4/24/2025Timothy RolphInsiderSell6,250$41.03$256,437.50 4/15/2025Catriona YaleInsiderSell9,073$37.91$343,957.43 4/10/2025Andrew ChengCEOSell30,000$35.23$1,056,900.00 4/7/2025Timothy RolphInsiderSell6,250$35.88$224,250.00 3/27/2025G. Walmsley GrahamDirectorBuy50,000$43.55$2,177,500.00 3/25/2025G. Walmsley GrahamDirectorBuy91,309$44.75$4,086,077.75 3/17/2025Catriona YaleInsiderSell10,000$44.76$447,600.00 3/12/2025Andrew ChengCEOSell1,738$44.88$78,001.44 3/12/2025Catriona YaleInsiderSell614$44.88$27,556.32 3/12/2025Jonathan YoungCOOSell607$44.88$27,242.16 3/12/2025William Richard WhiteCFOSell676$44.88$30,338.88 3/10/2025Andrew ChengCEOSell30,000$41.77$1,253,100.00 3/5/2025Timothy RolphInsiderSell12,500$44.53$556,625.00 3/4/2025Jonathan YoungCOOSell50,000$44.86$2,243,000.00 3/3/2025Patrick LamyVPSell1,000$48.09$48,090.00 2/18/2025Catriona YaleInsiderSell10,000$49.87$498,700.00 2/10/2025Andrew ChengCEOSell30,000$52.73$1,581,900.00 2/5/2025Timothy RolphInsiderSell18,750$56.51$1,059,562.50 2/3/2025Jonathan YoungCOOSell10,000$53.81$538,100.00 1/30/2025G. Walmsley GrahamDirectorBuy200,000$48.00$9,600,000.00 1/27/2025Andrew ChengCEOSell30,000$54.90$1,647,000.00 1/27/2025Patrick LamyVPSell5,000$57.03$285,150.00 1/27/2025Timothy RolphInsiderSell31,250$55.77$1,742,812.50 1/2/2025Jonathan YoungCOOSell10,000$28.03$280,300.00 12/16/2024Catriona YaleInsiderSell9,074$29.11$264,144.14 12/16/2024Patrick LamyVPSell1,000$29.13$29,130.00 12/10/2024Andrew ChengCEOSell7,855$30.79$241,855.45 12/10/2024Jonathan YoungCOOSell2,503$30.79$77,067.37 12/10/2024Patrick LamyVPSell925$30.79$28,480.75 12/10/2024Timothy RolphInsiderSell4,818$30.91$148,924.38 12/10/2024William Richard WhiteCFOSell2,817$30.79$86,735.43 12/2/2024Andrew ChengCEOSell25,000$32.09$802,250.00 12/2/2024Jonathan YoungCOOSell10,000$32.13$321,300.00 11/15/2024Catriona YaleInsiderSell9,061$27.73$251,261.53 11/1/2024Andrew ChengCEOSell108,366$31.73$3,438,453.18 11/1/2024Catriona YaleInsiderSell15,485$32.62$505,120.70 11/1/2024Jonathan YoungCOOSell50,716$31.57$1,601,104.12 10/30/2024Catriona YaleInsiderSell4,515$32.53$146,872.95 (Data available from 1/1/2013 forward) AKRO Insider Trading Activity - Frequently Asked Questions Who is on Akero Therapeutics' Insider Roster? The list of insiders at Akero Therapeutics includes Andrew Cheng, Catriona Yale, G. Walmsley Graham, Jonathan Young, Patrick Lamy, Scott A Gangloff, Seth Loring Harrison, Skorpios Trust, Timothy Rolph, Tomas J. Heyman, and William Richard White. Learn more on insiders at AKRO. What percentage of Akero Therapeutics stock is owned by insiders? 7.07% of Akero Therapeutics stock is owned by insiders. Learn more on AKRO's insider holdings. Which Akero Therapeutics insiders have been buying company stock? The following insider purchased AKRO shares in the last 24 months: G. Walmsley Graham ($18,691,577.75). How much insider buying is happening at Akero Therapeutics? Insiders have purchased a total of 491,309 AKRO shares in the last 24 months for a total of $18,691,577.75 bought. Which Akero Therapeutics insiders have been selling company stock? The following insiders have sold AKRO shares in the last 24 months: Andrew Cheng ($25,649,395.30), Catriona Yale ($5,943,164.96), Jonathan Young ($9,809,069.12), Patrick Lamy ($1,456,325.16), Scott A Gangloff ($46,504.32), Timothy Rolph ($9,172,148.30), and William Richard White ($7,253,564.40). How much insider selling is happening at Akero Therapeutics? Insiders have sold a total of 1,580,563 Akero Therapeutics shares in the last 24 months for a total of $59,330,171.56 sold. Akero Therapeutics Key ExecutivesDr. Andrew Cheng M.D. (Age 57)Ph.D., President, CEO & Director Compensation: $1.04MDr. Jonathan M. Young J.D. (Age 54)Ph.D., Co-Founder, Executive VP, COO & Secretary Compensation: $672.35kDr. Timothy Rolph (Age 70)Co-Founder & Chief Scientific Officer Compensation: $722.32k10 recent tradesMr. William R. White J.D. (Age 51)Executive VP, CFO, Treasurer & Head of Corporate Development Compensation: $678.06kMs. Catriona Yale (Age 52)Executive VP & Chief Development Officer Compensation: $678.06k6 recent tradesMr. Scott A. Gangloff (Age 50)Chief Technical Officer 1 recent tradesMr. David West J.D.Vice President of LegalMr. John J. Schembri (Age 62)Vice President & Head of Finance Mr. Patrick Lamy (Age 51)Senior Vice President of Commercial Strategy 7 recent trades More Insider Trading Tools from MarketBeat Related Companies Summit Therapeutics Insider Selling Viatris Insider Selling Roivant Sciences Insider Selling BridgeBio Pharma Insider Selling Moderna Insider Selling Elanco Animal Health Insider Selling Verona Pharma PLC American Depositary Share Insider Selling Revolution Medicines Insider Selling Avidity Biosciences Insider Selling Cytokinetics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles WesBanco Insiders Signal Confidence With Coordinated BuysBig Insider Sales at NVDA, DELL, TMUS Raise Questions—Or Do They?3 Healthcare Companies Insiders Are Buying Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's Comeback This page (NASDAQ:AKRO) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akero Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKRO Stock Alerts